Leukemia News and Research

RSS

Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.

Mitophagy helps blood cancer cells to evade the killing effects of BH3 mimetic drug

Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often adopt features that let them evade the drugs' effects within a year.

24 Apr 2023

Novel cell signaling pathway could be targeted against aggressive pancreatic cancers

Researchers at the Johns Hopkins Kimmel Cancer Center identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.

24 Apr 2023

Exposure to 4 or more CT scans before adulthood doubles the risk for cancers

For children under age 18 years, a single computed tomography (CT) scan is not associated with an increased risk of brain tumors, leukemia or lymphoma, but exposure to 4 or more scans before adulthood more than doubles the risk, according to new research https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221303 in CMAJ.

24 Apr 2023

Overcoming challenges in Point of Care diagnostics in veterinary medicine

In this interview, we speak to Dr. Naomi Urbina, senior scientist at Fortis, about recent developments in Point of Care diagnostics in veterinary medicine, and about how Nanocomposix services can help overcome potential challenges in the field.

From nanoComposix 24 Apr 2023

Researchers discover the molecule responsible for guiding T cells toward tumors

Immunotherapy, particularly CAR T-Cell treatment for cancer, is extending the lives of many patients. But sometimes the therapy randomly migrates to places it shouldn't go, tucking into the lungs or other noncancerous tissue and causing toxic side effects.

18 Apr 2023

Children with ALL living in extreme poverty face two-fold greater risk of relapse

Children with acute lymphoblastic leukemia (ALL) who live in extreme poverty and were undergoing maintenance therapy faced an almost two-fold greater risk of relapse compared with kids who weren't as poor, according to a study published in today's issue of Blood.

18 Apr 2023

New $2.3 million NCI grant awarded to Georgia Cancer Center to improve survival of patients with AML

Acute myeloid leukemia (AML) is a cancer that affects blood cells in the bone marrow -; the spongy tissue inside certain bones, where new blood cells are made.

17 Apr 2023

A review of the risk factors associated with cancer evolution

Researchers reviewed existing data on tumor-promotive risk factors and their underlying mechanisms.

17 Apr 2023

Researchers show how the EBV virus exploits genomic weaknesses to cause cancer

The Epstein-Barr virus (EBV) is easily spread through bodily fluids, primarily saliva, such as kissing, shared drinks or using the same eating utensils.

13 Apr 2023

For uninsured people with cancer, securing care can be like spinning a roulette wheel

Eighteen months after April Adcox learned she had skin cancer, she finally returned to Charleston's Medical University of South Carolina last May to seek treatment.

10 Apr 2023

Ultra-processed food and cancer: is there a link?

Researchers performed a meta-analysis to evaluate the relationship between ultra-processed food and cancer.

5 Apr 2023

Promising new combination of drugs identified to treat juvenile myelomonocytic leukemia

Indiana University School of Medicine researchers have identified a promising new combination of drugs to treat juvenile myelomonocytic leukemia (JMML), a rare form of blood cancer that affects children.

5 Apr 2023

Study explains why leukemia survivors experience negative effects on blood formation decades later

Contrary to previous belief, stem cells, from which all new blood cells are formed, remain in bone marrow in the blood cancer type acute lymphocytic leukemia.

5 Apr 2023

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

The scientific foundation needed to work on curing a class of cancer-causing mutations is here, in the form of a tool from St. Jude Children's Research Hospital.

5 Apr 2023

UCSD engineers develop a biodegradable polymer system to treat rheumatoid arthritis

A team led by engineers at the University of California San Diego has developed a biodegradable polymer system to treat rheumatoid arthritis, an autoimmune and inflammatory disease, by working in concert with the power of the human immune system.

4 Apr 2023

CAR T-cell therapy improves quality of life for patients with blood cancers

Chimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, yet relatively few studies have investigated the impact of the therapy on longitudinal patient quality of life – an aspect of care that often suffers from receiving traditional intensive cancer medications, such as chemotherapy.

30 Mar 2023

New research may upend long-held scientific dogma about short telomeres and cancer risk

Johns Hopkins Medicine scientists say their 20-year study of more than 200 people with premature aging syndromes caused by abnormally short telomeres, or shortened repetitive DNA sequences at the ends of chromosomes, may upend long-held scientific dogma and settle conflicting studies about how and whether short telomeres contribute to cancer risk.

30 Mar 2023

Leukemia News and Research

Further Reading

Mitophagy helps blood cancer cells to evade the killing effects of BH3 mimetic drug

Novel cell signaling pathway could be targeted against aggressive pancreatic cancers

Exposure to 4 or more CT scans before adulthood doubles the risk for cancers

Overcoming challenges in Point of Care diagnostics in veterinary medicine

Researchers discover the molecule responsible for guiding T cells toward tumors

Children with ALL living in extreme poverty face two-fold greater risk of relapse

New $2.3 million NCI grant awarded to Georgia Cancer Center to improve survival of patients with AML

A review of the risk factors associated with cancer evolution

Researchers show how the EBV virus exploits genomic weaknesses to cause cancer

For uninsured people with cancer, securing care can be like spinning a roulette wheel

Ultra-processed food and cancer: is there a link?

Promising new combination of drugs identified to treat juvenile myelomonocytic leukemia

Study explains why leukemia survivors experience negative effects on blood formation decades later

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

UCSD engineers develop a biodegradable polymer system to treat rheumatoid arthritis

CAR T-cell therapy improves quality of life for patients with blood cancers

New research may upend long-held scientific dogma about short telomeres and cancer risk

Notorious oncogene plays a direct role in disguising growing cancers from the immune system

Scientists develop a marker for therapy response in acute myeloid leukemia

Study focuses on new approach that delivers a "one-two punch" to help T cells attack solid tumors

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News